Poggio, A.; Sullivan, A.P.; Rampa, L.; Andrade, J.G.; Anselmino, M.
Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation. Medicina 2025, 61, 1200.
https://doi.org/10.3390/medicina61071200
AMA Style
Poggio A, Sullivan AP, Rampa L, Andrade JG, Anselmino M.
Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation. Medicina. 2025; 61(7):1200.
https://doi.org/10.3390/medicina61071200
Chicago/Turabian Style
Poggio, Alan, Andrew P. Sullivan, Lorenzo Rampa, Jason G. Andrade, and Matteo Anselmino.
2025. "Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation" Medicina 61, no. 7: 1200.
https://doi.org/10.3390/medicina61071200
APA Style
Poggio, A., Sullivan, A. P., Rampa, L., Andrade, J. G., & Anselmino, M.
(2025). Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation. Medicina, 61(7), 1200.
https://doi.org/10.3390/medicina61071200